39
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Prolonged and Profound Acid Inhibition Is Crucial in Helicobacter pylori Treatment with a Proton Pump Inhibitor Combined with Amoxicillin

Pages 39-43 | Published online: 08 Jul 2009

REFERENCES

  • Soll AH, for the practice parameters committee of the American College of Gastroenterology. Medical treatment of peptic ulcer disease. Practice guidelines. JAMA 1996;275:622–9.
  • Gad A, Unge P. Antibacterial therapy of Helicobacter pylori- associated peptic ulcer disease: a new strategy [editorial]. J Clin Gastroenterol 1994;19:6–10.
  • Axon ATR. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994;29 Suppl 201:16–23.
  • McGowan CC, Cover TL, Blaser MJ. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. Gastroenterology 1994;107: 738–43.
  • McNulty CAM. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection. In: Rathbone BJ, Heatley RV, editors. Campylobacter pylori and gastroduodenal disease. Oxford: Blackwell Scientific Publications; 1989. p. 209–16.
  • Labenz J, Stolte M, Blum AL, Jorias I, Leverkus F, Sollböhmer M, et al. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin. Gut 1995;37: 39–43.
  • Gad A. Campylobacter pylori and gastroduodenal disease. Clinical and morphological correlations. In: Bertaccini G, Cheli R, Dobrilla G, editors. The duodenum. Cortina: International Raven Press; 1988. p. 119–30.
  • Sjöstedt S, Kager L, Veress B, Nord CE. Campylobacter pylori in relation to other aerobic and anaerobic microorganisms in patients with gastric disease. Microb Ecol Health Dis 1989; 2:107–14.
  • Nilsson G. Increased plasma gastrin levels in connection with inhibition of gastric acid responses to sham feeding following bulbar perfusion with acid in dogs. Scand J Gastroenterol 1975; 10:273–7.
  • Bayerdörffer E, Mannes GA, Sommer A, Höchter W, Weingart J, Hatz R, et al. High dose omeprazole treament combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992;4:697–702.
  • Meyer-Rosberg K, Scott DR, Rex D, Melchers K, Sachs G. The effect of environmental pH on the proton motive force of Helicobacter pylori. Gastroenterology 1996;111: 886–900.
  • Unge P, Gad A, Eriksson K, Bergman B, Carling L, Ekström P, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 1993;5:325–31.
  • Bertilsson L, Lou Y-Q, Du Y-L, Liu Y, Kuang T-Y, Liao X-M, et al. Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin. Clin Pharmacol Ther 1992;51: 388–97.
  • McColl KEL, Nujumi AM El, Dorrian CA, Macdonald AMI, Fullarton GM, Harwood J. Helicobacter pylori and hypergas-trinaemia during proton pump inhibitor therapy. Scand J Gastroenterol 1992;27:93–8.
  • Chittajallu RS, Neithercut WD, Ardill JES, McColl KEL. Helicobacter pylori-related hypergastrinaemia is not due to elevated antral surface pH. Scand J Gastroenterol 1992;27:218–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.